Option chain shows key data for Uxin's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Uxin.

Uxin (NASDAQ:UXIN) Stock, Option Chain

Uxin

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AKTS

ALLT

APTO

ARQQ

CDXC

DBGI

ELAB

GORO

KULR

LION

NIVF

Nuveen California Dividend Advantage Municipal Fund 2

QMCO

QUBT

RGTI

UXIN

XCUR

XTKG

Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Asia

Penny Stocks

Small Cap

General

ATHM

CANG

Key Takeaways:


	Cango is aggressively building up a customer base and support services to export Chinese cars to the rest of the world, with 60,000 registered users for its AutoCango.com site


Cango Builds Up Global Capabilities In Search Of New Direction

Autoliv

Intraday Update

CLPT

IONQ

ISRG

NFLX

OKLO

PTON

Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday

Uxin Limited - American Depositary Shares

Uxin Ltd

Bitcoin Holdings Update
On November&nbsp;25, 2024, the Company announced that, during the period between November&nbsp;18, 2024 and November&nbsp;24, 2024, the Company acquired approximately 55,500 bitcoins for approximately $5.4&nbsp;billion in cash, at an average price of approximately $97,862 per bitcoin, inclusive of fees and expenses. The bitcoin purchases were made using proceeds from the Convertible Notes Offering and the issuance and sale of Shares under the Sales Agreement.
As of November&nbsp;24, 2024, the Company, together with its subsidiaries, held an aggregate of approximately&nbsp;386,700 bitcoins, which were acquired at an aggregate purchase price of approximately&nbsp;$21.9&nbsp;billion and an average purchase price of approximately $56,761 per bitcoin, inclusive of fees and expenses.

MSTR

MicroStrategy Acquired 55.5K Bitcoins For $5.4B At $97,862 Each; Total Holdings Reach 386.7K Bitcoins Valued At $21.9B

Biotech

NRXP

NRx Pharmaceuticals Publishes Study In American Journal Of Clinical Psychopharmacology Highlighting Enhanced Depression Rating Reliability In Phase 2b/3 NRX-101 Trial, Supporting Future Registration Trials For Antidepressant Drugs

B of A Securities analyst Geoff Meacham maintains BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Buy and raises the price target from $42 to $45.

Price Target

Analyst Ratings

BBIO

B of A Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $45

CTXR

Citius Pharmaceuticals Announces Type C Meeting With FDA, Says FDA Provided Guidance Underscoring Pathway To Support A Future NDA Submission For Mino-Lok

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">143.6300</td>
<td align="right">0.980</td>
<td align="right">0.68</td>
<td>1.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.0100</td>
<td align="right">0.280</td>
<td align="right">0.55</td>
<td>94.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">144.8211</td>
<td align="right">0.661</td>
<td align="right">0.45</td>
<td>3.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">234.6500</td>
<td align="right">1.050</td>
<td align="right">0.44</td>
<td>29.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.7750</td>
<td align="right">0.325</td>
<td align="right">0.39</td>
<td>17.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">44.2600</td>
<td align="right">0.170</td>
<td align="right">0.38</td>
<td>1.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">97.6367</td>
<td align="right">0.367</td>
<td align="right">0.37</td>
<td>10.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.9900</td>
<td align="right">0.150</td>
<td align="right">0.18</td>
<td>6.6K</td>
</tr>
</tbody>
</table>
No loser in today's Pre-market session. 
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

ETFs

XLRE

Leading And Lagging Sectors For November 25, 2024

WIIM

BHVN

Biohaven shares are trading lower after the company announced its treatment arm of the RESILIENT SMA study did not statistically separate on the primary outcome at Week 48 compared to the placebo+standard of care group.

DA Davidson analyst Linda Bolton Weiser maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Buy and maintains $170 price target.

DA Davidson Maintains Buy on e.l.f. Beauty, Maintains $170 Price Target

IMNN

IMUNON Secures FDA Support For Phase 3 Trial Of IMNN-001 In Advanced Ovarian Cancer, Plans To Submit Final Protocol In December And Launch 500-Patient Study In Q1 2025

VSTE

Vast shares are trading higher after the company signed an updated funding agreement to access up to $30 million of its $65 million grant from the Australian Renewable Energy Agency.

-- Webcast to be held on Monday, December 2, 2024 at 8:30 AM Eastern Time --
Rallybio Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced that the Company will host a webcast to provide a program update on RLYB116, its innovative, once-weekly, small volume, subcutaneously injected C5 inhibitor in development for the treatment of patients with complement-mediated diseases. The webcast will take place on Monday, December 2 at 8:30 AM Eastern Time and will review recent manufacturing process enhancements, biomarker characterization analyses, and the Company's future plans for the program.
Webcast Information
The live webcast may be accessed by visiting Rallybio's website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.rallybio.com&amp;esheet=54157145&amp;newsitemid=20241122010570&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestors.rallybio.com&amp;index=1&amp;md5=ebebb87ed962863ea700cd114690d68e">http://investors.rallybio.com</a>. A replay and accompanying slides of the webcast will be available on the Rallybio website for 30 days following the event.

RLYB

Rallybio To Provide Update On RLYB116 Program, An Innovative Subcutaneously Injected C5 Inhibitor; Webcast To Be Held On Monday, December 2, 2024 At 8:30 am ET

SAVA

Cassava Sciences  shares are trading lower after the company announced Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study.

ALUR

Allurion Launches AllurionMeds In The U.S., Combining AI-Driven GLP-1 Weight Loss Program With Coach Iris For Long-Term Maintenance, Expanding Reach To All 50 States And Advancing Mission To Combat Obesity

BridgeBio Pharma shares are trading higher after the company announced that the FDA approved Attruby to treat adults with ATTR-CM. Also, HC Wainwright maintained a Buy rating on the stock and raised its price target from $43 to $49.

Small Cap Consumer Research analyst Eric Beder reiterates Guess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) with a Buy and maintains $29 price target.

Reiteration

Small Cap Consumer Research Reiterates Buy on Guess, Maintains $29 Price Target

Canaccord Genuity analyst Joseph Vafi maintains MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) with a Buy and raises the price target from $300 to $510.

Canaccord Genuity Maintains Buy on MicroStrategy, Raises Price Target to $510

Financing

Vast Signs Updated Funding Agreement To Access Up To $30M Of Its $65M Grant From The Australian Renewable Energy Agency

Brightcove Stockholders to Receive $4.45 Per Share in Cash
Bending Spoons enters the enterprise SaaS market and will draw on its technology expertise to further strengthen Brightcove and bring its cutting-edge platform to new heights
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fprotect-us.mimecast.com%2Fs%2FTT0ACXD7rNIDpARJTkWLIt%3Fdomain%3Dbrightcove.com&amp;esheet=54157477&amp;newsitemid=20241124779994&amp;lan=en-US&amp;anchor=Brightcove+Inc.&amp;index=1&amp;md5=4089cc9217606a25bce452fc6f364d4e">Brightcove Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCOV#NASDAQ">BCOV</a>), the world's most trusted streaming technology company, today announced that it has entered into a definitive agreement to be acquired by Bending Spoons, in an all-cash transaction valued at approximately $233 million. Under the terms of the agreement, Brightcove shareholders will receive $4.45 per share in cash for each share of Brightcove common stock that they own. The per share purchase price represents a 90% premium over Brightcove's 60-day volume weighted average share price as of the close on November 22, 2024.

BCOV

Brightcove Enters Into Definitive Agreement To Be Acquired By Bending Spoons For $233M; Brightcove Stockholders To Receive $4.45 Per Share In Cash

Tsetsaut Skii km Lax Ha Nation Files For Judicial Review Of B.C.'s Substantial Start Determination For Seabridge Gold's KSM Mine; Despite Seabridge's Plan To Locate The Mine's Immense Toxic Waste Facilities On The Nation's Exclusive Traditional Territory, The Province Has Not Engaged In The Meaningful Consultation Required By The Canadian Constitution

TOYO

Toyo Co. To Acquire Texas-Based Solar Module Manufacturing Facility With Initial 2.5 GW Capacity, Plans Expansion To 6.5 GW By 2029 To Meet U.S. Demand For American-Made Solar Panels; Financial Terms Not Disclosed

B of A Securities analyst Alec Stranahan downgrades Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) from Buy to Neutral and lowers the price target from $24 to $6.

Downgrades

CATX

B of A Securities Downgrades Perspective Therapeutics to Neutral, Lowers Price Target to $6

Uxin Limited (UXIN) Q1 2025 Earnings Call Transcript

Uxin eyes EBITDA profitability ahead, posts smaller loss; shares rise

Uxin's High-Speed Pursuit Of Profit: Debt-Driven Expansion

These consumer sector stocks have seen the biggest gains off the China stimulus developments

Uxin (UXIN) has released an update. Uxin, a leading used car retailer in China, has entered a strategic partnership with Wuhan City Economic & Tech...

Uxin Forms Strategic Partnership to Expand in Wuhan

09:54 EDT Uxin (UXIN) Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving bre...

Uxin Ltd trading halted, volatility trading pause

10:04 EDT Uxin (UXIN) Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try...

Uxin Ltd trading resumes

Uxin (UXIN) has released an update. Uxin Limited, a leading used car retailer in China, has announced a share subscription agreement with Lightwind...

Uxin Limited Strengthens Market Position with Share Agreement

Uxin Non-GAAP EPS of $0.00, revenue of $70.85M

Uxin (UXIN) announced that the company's board of directors approved a change of the company's fiscal year end from March 31 to December 31 each ye...

Uxin announces change of fiscal year end

BZUN

CAAS

DADA

DOGZ

KNDI

MNSO

TOUR

Press Releases

Uxin Announces Strategic Partnership with Zhengzhou Airport Industry

Uxin to Report Fourth Quarter and Fiscal Year 2024 Financial Results on July 31, 2024

Earnings

Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

Contracts

Uxin Announces Entry into a Memorandum of Understanding for a Proposed Investment

Uxin to Report First Quarter Fiscal Year 2025 Financial Results on September 23, 2024

Uxin Reports Unaudited First Quarter of Fiscal Year 2025 Financial Results

Uxin Announces Strategic Partnership with Wuhan City Economic & Technological Development Zone

Uxin to Report Second Quarter Fiscal Year 2025 Financial Results on November 25, 2024

Uxin Announces Change of Fiscal Year End

Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024

Advance Auto Parts

Asbury Automotive Gr

AutoNation

ARKO

Autozi Internet Technology (Global) Ltd. - Class A Ordinary Shares

Autozi Internet Tech

AutoZone

Cango Inc. American Depositary Shares, each representing two (2) Class A Ordinary Shares

Cango

America's Car-Mart

Carvana

Camping World Holdings, Inc. Class A Common Stock

Camping World Holdings

EVgo

Lazydays Hldgs

Group 1 Automotive

CarMax

Lithia Motors

Monro

Murphy USA

NaaS Technology Inc. - American Depositary Shares

Naas Technology

OneWater Marine Inc. - Class A Common Stock

OneWater Marine

O'Reilly Automotive

Penske Automotive Group, Inc. Common Stock

Penske Automotive Group

CarParts.com

RumbleON

Sonic Automotive

Valvoline

Uxin shares are trading higher after the company reported Q2 sales of $70.85 million, up from $48.80 million year-over-year.

Comments

Uxin

Uxin (UXIN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga